Publications for William E. Dager william.dager@tu.edu
Haines, S. T., Dager, W. E., & Trujillo, T. C. (2010). Clinical and management challenges in preventing venous thromboembolism in health systems: A case-based panel discussion. American Journal of Health-System Pharmacy, 67(10 Suppl. 6), S26-S30. doi:10.2146/ajhp100179
Matzke, G. R., Dager, W. E., & Heintz, B. H. (2010). Dialysis of drugs. In K. M. Smith, D. M. Riche, & N. N. Henyan (Eds.), Clinical drug data (11th ed., pp. 1132-1140). New York, NY: McGraw-Hill.
Matzke, G. R., Dager, W. E., & Heintz, B. H. (2010). Renal disease. In K. M. Smith, D. M. Riche, & N. N. Henyan (Eds.), Clinical drug data (11th ed., pp. 1123-1131). New York, NY: McGraw-Hill.
Nishijima, D. K., Dager, W. E., Schrot, R. J., & Holmes, J. F. (2010). The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage. Academic Emergency Medicine, 17(3), 244-251. doi:10.1111/j.1553-2712.2010.00666.x
Prinzola, J. L., Smythe, M. A., & Dager, W. E. (2010). Drug-induced thrombocytopenias in the critically ill. Critical Care Medicine, 38(Suppl. 6), S145-S154. doi:10.1097/CCM.0b013e3181de0b88
Wittkowsky, A., Spinler, S., Dager, W. E., Gulseth, M., & Nutescu, M. (2010). Dosing guidelines, not protocols, for managing warfarin therapy. American Journal of Health-System Pharmacy, 67(18), 1554-1556. This material can be found here.
Dager, W. E. (2009). Dosing nomograms: Silos on a slope [editorial]. Annals of Pharmacotherapy, 43(1), 114-117. This material can be found here.
Dobesh, P. P., Wittkowsky, A. K., Stacy, Z., Dager, W. E., Haines, S. T., Lopez, L. M.,...Vondracek, T. (2009). Key articles and guidelines for the prevention of venous thromboembolism. Pharmacotherapy, 29(4), 410-458. This material can be found here.
Erstad, B. L., Brophy, G. M., Martin, S. J., Haas, C. E., Devlin, J. W., Welage, L. S., & Dager, W. E. (2009). Key articles and guidelines relative to intensive care unit pharmacology: 2009 update. Pharmacotherapy, 29(10), 1228-1269. This material can be found here.
Gulseth, M., Grice, G., & Dager, W. E. (2009). Pharmacogenomics of Warfarin: Uncovering a piece of the Warfarin mystery. American Journal of Health-System Pharmacy, 66(2), 123-133.
Heintz, B. H., Matzke, G. R., & Dager, W. E. (2009). Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy, 29(5), 562-577. This material can be found here.
Nutescu, E. A., Spinler, S. A., Wittkowsky, A., & Dager, W. E. (2009). Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Annals of Pharmacotherapy, 43(6), 1064-1083. This material can be found here.